Ratings by Piper Sandler (William Quirk)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/10/2023 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2023 | Becton Dickinson | BDX | Upgrade | Overweight (Neutral) |
263.61 (207.09) |
-21.44% | Details | |
| 2/3/2023 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2022 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2022 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/8/2021 | Becton Dickinson | BDX | Downgrade | Neutral (Overweight) |
246.14 (167.12) |
-32.1% | Details | |
| 8/2/2021 | Avantor Inc. | AVTR | Upgrade | Overweight (Neutral) |
37.23 (8.17) |
-78.06% | Details | |
| 5/7/2021 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2021 | Avantor Inc. | AVTR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2021 | Luminex | LMNX | Downgrade | Neutral (Overweight) |
37.03 (14.92) |
-59.71% | Details | |
| 3/31/2021 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2021 | Heska Corp. | HSKA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2021 | Pacific Biosciences of California | PACB | Upgrade | Overweight (Neutral) |
45.90 (1.38) |
-96.99% | Details | |
| 2/10/2021 | OncoCyte Corp | OCX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2021 | Avantor Inc. | AVTR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/22/2020 | Illumina | ILMN | Upgrade | Overweight (Neutral) |
366.06 (124.62) |
-65.96% | Details | |
| 12/16/2020 | OncoCyte Corp | OCX | Upgrade | Overweight (Neutral) |
2.12 (3.20) |
50.94% | Details | |
| 11/6/2020 | Heska Corp. | HSKA | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2020 | Pacific Biosciences of California | PACB | Downgrade | Neutral (Overweight) |
13.11 (1.38) |
-89.47% | Details | |
| 10/8/2020 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/1/2020 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 8/18/2020 | Luminex | LMNX | New Coverage | Overweight (N/A) |
30.87 (14.92) |
-51.67% | Details | |
| 8/7/2020 | Illumina | ILMN | Downgrade | Neutral (Overweight) |
400.74 (124.62) |
-68.9% | Details | |
| 7/30/2020 | Avantor Inc. | AVTR | Maintain | Neutral (N/A) |
|
Details | ||
| 7/1/2020 | OncoCyte Corp | OCX | Downgrade | Neutral (Overweight) |
3.23 (3.20) |
-0.93% | Details | |
| 6/29/2020 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2020 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2020 | Myriad Genetics | MYGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/24/2020 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2020 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2020 | Accelerate Diagnostics | AXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2020 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2020 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2020 | Fluidigm Corporation | FLDM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/7/2020 | Avantor Inc. | AVTR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2020 | Myriad Genetics | MYGN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/6/2020 | Becton Dickinson | BDX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/31/2020 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2020 | Danaher | DHR | Maintain | Neutral (N/A) |
|
Details | ||
| 1/30/2020 | Hologic | HOLX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/28/2020 | PerkinElmer | PKI | Maintain | Neutral (N/A) |
|
Details | ||
| 1/24/2020 | Accelerate Diagnostics | AXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/9/2020 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2019 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2019 | Pacific Biosciences of California | PACB | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2019 | Accelerate Diagnostics | AXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2019 | Hologic | HOLX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2019 | Myriad Genetics | MYGN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2019 | Luminex | LMNX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2019 | Fulgent Genetics | FLGT | Upgrade | Overweight (Neutral) |
9.41 (16.50) |
75.35% | Details | |
| 11/1/2019 | Axonics Modulation Technologies Inc. | AXNX | New Coverage | Overweight (N/A) |
23.50 (70.98) |
202.04% | Details | |
| 10/31/2019 | PerkinElmer | PKI | Downgrade | Neutral (Overweight) |
87.99 (115.24) |
30.97% | Details | |
| 10/31/2019 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2019 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/24/2019 | Edwards Lifesciences | EW | Maintain | Overweight (N/A) |
|
Details | ||
| 10/15/2019 | Pacific Biosciences of California | PACB | Upgrade | Overweight (Neutral) |
5.13 (1.38) |
-73.1% | Details | |
| 10/8/2019 | Qiagen NV | QGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/23/2019 | Edwards Lifesciences | EW | New Coverage | Overweight (N/A) |
219.66 (81.64) |
-62.83% | Details | |
| 9/18/2019 | Heska Corp. | HSKA | New Coverage | Neutral (N/A) |
69.12 (119.99) |
73.6% | Details | |
| 8/15/2019 | OncoCyte Corp | OCX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/15/2019 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2019 | Myriad Genetics | MYGN | Downgrade | Neutral (Overweight) |
45.28 (5.15) |
-88.63% | Details | |
| 8/9/2019 | Accelerate Diagnostics | AXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2019 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2019 | Fluidigm Corporation | FLDM | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2019 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2019 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2019 | Hologic | HOLX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2019 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/29/2019 | Genomic Health Inc. | GHDX | Downgrade | Neutral (Overweight) |
68.66 (63.44) |
-7.6% | Details | |
| 7/25/2019 | Laboratory Corporation of America | LH | Maintain | Overweight (N/A) |
|
Details | ||
| 6/20/2019 | Genomic Health Inc. | GHDX | Upgrade | Overweight (Neutral) |
54.29 (68.66) |
26.47% | Details | |
| 6/11/2019 | Agilent | A | New Coverage | Overweight () |
69.52 (115.07) |
65.52% | Details | |
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Neutral (N/A) |
17.20 (8.17) |
-52.5% | Details | |
| 6/11/2019 | Danaher | DHR | New Coverage | Neutral (N/A) |
137.52 (195.50) |
42.16% | Details | |
| 6/10/2019 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/17/2019 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2019 | Myriad Genetics | MYGN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2019 | Genomic Health Inc. | GHDX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/1/2019 | Meridian Biosciences | VIVO | Upgrade | Neutral (Underweight) |
13.45 (33.97) |
152.57% | Details | |
| 4/26/2019 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2019 | Hologic | HOLX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/5/2019 | Illumina | ILMN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/13/2019 | Fluidigm Corporation | FLDM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2019 | Masimo Corp. | MASI | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2019 | OncoCyte Corp | OCX | New Coverage | Overweight (N/A) |
3.87 (3.23) |
-16.54% | Details | |
| 2/5/2019 | Luminex | LMNX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2018 | Masimo Corp. | MASI | Upgrade | Overweight (Neutral) |
104.84 (175.42) |
67.32% | Details | |
| 11/8/2018 | Hologic | HOLX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2018 | Quidel Corp. | QDEL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2018 | Myriad Genetics | MYGN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2018 | Genomic Health Inc. | GHDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2018 | Accelerate Diagnostics | AXDX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2018 | Fluidigm Corporation | FLDM | Upgrade | Overweight (Neutral) |
7.20 (3.71) |
-48.47% | Details | |
| 11/1/2018 | Masimo Corp. | MASI | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2018 | Illumina | ILMN | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/10/2018 | Myriad Genetics | MYGN | Upgrade | Overweight (Neutral) |
43.02 (45.28) |
5.25% | Details | |
| 10/2/2018 | Illumina | ILMN | Maintain | Overweight (Overweight) |
|
Details | ||
| 9/25/2018 | Quest Diagnostics | DGX | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/5/2018 | CareDx, Inc | CDNA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/22/2018 | Myriad Genetics | MYGN | Maintain | Neutral (N/A) |
|
Details |
